References
- Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1–3. doi:10.1126/science.296.5573.1655.
- Cortés I, Sánchez-Ruíz J, Zuluaga S, Calvanese V, Marques M, Hernandez C, Rivera T, Kremer L, Gonzalez-Garcia A, Carrera AC, et al. p85β phosphoinositide 3-kinase subunit regulates tumor progression. Proc Natl Acad Sci USA. 2012;109(28):11318–11323. doi:10.1073/pnas.1118138109.
- Rao L, Mak VC, Zhou Y, Zhang D, Li X, Fung CCY, Sharma R, Gu C, Lu Y, Tipoe GL, et al. p85β regulates autophagic degradation of AXL to activate oncogenic signaling. Nat Commun. 2020;11(1):2291. doi:10.1038/s41467-020-16061-7.
- Lozneanu L, Pinciroli P, Ciobanu DA, Carcangiu ML, Canevari S, Tomassetti A, Căruntu I-D. Computational and immunohistochemical analyses highlight AXL as a potential prognostic marker for ovarian cancer patients. Anticancer Res. 2016;36:4155–4163.
- Rankin EB, Fuh KC, Taylor TE, Krieg AJ, Musser M, Yuan J, Wei K, Kuo CJ, Longacre TA, Giaccia AJ, et al. AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res. 2010;70(19):7570–7579. doi:10.1158/0008-5472.CAN-10-1267.
- Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. Regulation of the p85/p110 phosphatidylinositol 3ʹ-kinase: stabilization and inhibition of the p110α catalytic subunit by the p85 regulatory subunit. Mol Cell Biol. 1998;18(3):1379–1387. doi:10.1128/MCB.18.3.1379.
- Valverde P. Effects of Gas6 and hydrogen peroxide in AXL ubiquitination and downregulation. Biochem Biophys Res Commun. 2005;333(1):180–185. doi:10.1016/j.bbrc.2005.05.086.
- Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa JP, et al. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature. 2014;507(7493):508–512. doi:10.1038/nature12998.
- Cheung LW, Walkiewicz KW, Besong TM, Guo H, Hawke DH, Arold ST, Mills GB. Regulation of the PI3K pathway through a p85α monomer–homodimer equilibrium. Elife. 2015;4:e06866. doi:10.7554/eLife.06866.
- Chamberlain MD, Oberg JC, Furber LA, Poland SF, Hawrysh AD, Knafelc SM, McBride HM, Anderson DH. Deregulation of Rab5 and Rab4 proteins in p85R274A-expressing cells alters PDGFR trafficking. Cell Signal. 2010;22(10):1562–1575. doi:10.1016/j.cellsig.2010.05.025.